Cargando…
Antibacterials and Acute Exacerbation of Chronic Bronchitis: Issues for Formulary Decision Makers
The utility of antibacterials in the management of acute exacerbations of chronic bronchitis (AECB) and the related lung pathology, chronic obstructive pulmonary disease (COPD), has been debated for decades. Data presented in this article document that more expensive antimicrobials may be favored in...
Autores principales: | Chock, Alan, Gong, Vera, Destache, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149187/ http://dx.doi.org/10.2165/00115677-200210060-00001 |
Ejemplares similares
-
Critical Review of Prasugrel for Formulary Decision Makers
por: Schafer, Jeremy
Publicado: (2009) -
Evaluating the Presence of Cognitive Biases in Health Care Decision Making: A Survey of U.S. Formulary Decision Makers
por: Mezzio, Dylan J., et al.
Publicado: (2018) -
Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease
por: Milder, Tamara Y., et al.
Publicado: (2020) -
Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy
por: Saint, Sanjay, et al.
Publicado: (2001) -
Living Health Technology Assessment: Issues, Challenges and Opportunities
por: Thokala, Praveen, et al.
Publicado: (2023)